New Wave of Foreclosures Will Sink the Housing Market Rebound

The long-anticipated housing market rebound will hit a speed bump this year as the number of foreclosures rises again.

With January's mammoth $26 billion settlement between five major banks and a group of state attorneys general, foreclosures that had been held up for a year or more are now moving forward.

The spike in foreclosures will arrive just as other data, such as the 5.1% increase in new construction permits reported on Tuesday, had begun to point to a housing market rebound.

"We expect to see foreclosure-related sales increase in 2012, particularly pre-foreclosure sales, as lenders start to more aggressively dispose of distressed assets held up by the mortgage servicing gridlock over the past 18 months," Brandon Moore, CEO of RealtyTrac, told CNN Money.

RealtyTrac's February report showed new default notices - the first step in the foreclosure process - were up 1% from January. Default notices increased dramatically in some states, such as Pennsylvania (35%), Florida (33%) and Indiana (37%).

"The pig is starting to move through the python," Daren Blomquist, director of marketing for RealtyTrac, told CNN Money.

Distressed sales already account for about one out of three U.S. home sales.

The National Association of Realtors (NAR) reported this week that 20% of home sales in February were foreclosures and 14% were short sales.

In a short sale, an owner who owes more on their home than it's worth agrees to sell for less, with the bank agreeing to accept the loss.

That's a far cry from a normal housing market, when distressed sales are less than 5%.

For 2012, RealtyTrac predicts a 25% increase in foreclosures, which will push the portion of distressed sales even higher.

And the picture doesn't figure to improve for quite some time. Paul Dales of Capital Economics estimates as many as an additional 3 million foreclosures over the! next se veral years.

The Uneven Impact on the Housing Market

However, the impact of this wave of foreclosures will be felt unevenly.

All of the states that saw increases in new default notices were those in which the courts play a role in foreclosures. The robo-signing issues addressed in the bank settlement occurred almost exclusively in such states.

States that don't use a judicial foreclosure process didn't accumulate a backlog. In fact, foreclosure activity in those states was down 5% in February from the previous month, and down 23% from the February 2011.

But among the 26 states that use a judicial foreclosure process, activity rose 2% in February from the month before. Foreclosure activity was up 24% from the previous year.

That leaves little room for optimism in hard-hit states such as Florida.

The loosening logjam in distressed sales will increase the downward pressure on prices by adding to inventory and lowering home values. Discounts on foreclosure sales typically range from 20%-30%.

And unlike some other housing market data, home prices haven't shown much evidence of turning upward. Home prices fell 4% in 2011 on top of the 30% decline since the peak of the housing bubble in June 2006.

Given the impact of the bank settlement, the outlook for home prices in 2012 isn't great.

"Enough homes are in the foreclosure pipeline to keep house prices falling through much of this year," Celia Chen, a housing economist atMoody'sAnalytics, told the Los Angeles Times.

While that may be good news for first-time homebuyers, it's terrible news for the 25% of homeowners who owe more on their mortgage than their homes are worth.

And it can only trip up the housing market rebound many analysts have been seeing in other recent housing data.

Construction of single-family homes is 18% above year-ago levels.! Permits for new single-family homes were up 4.9% in February. Existing home sales in February were up 8.8% from last year, and were up in 2011 to 4.26 million, from 4.10 million in 2010.

But none of that will be able to overcome a tsunami of foreclosures, at least for this year.

"While beginning to improve, a strong, sustained recovery in the housing market, especially the important single-family sector, still appears to be a ways off," Steven Wood, president of Insight Economics LLC, told Bloomberg News.

Spain, Italy weigh on Europe stocks; banks drop

LONDON (MarketWatch)'European stock markets ended lower in a choppy session as losses for banks weighed on sentiment Tuesday and Spanish and Italian bond yields surged on debt concerns.
The Stoxx Europe 600 index XX:SXXP 'closed down 1.1% at 264.29, after trading as high as 267.62 earlier in the day.
In Spain, the IBEX 35 index XX:IBEX 'tumbled 2.7% to 7,824.50, while yields on 10-year Spanish government bonds ES:10YR_ESP 'rose 9 basis points to 5.41%.
'One cannot say with any conviction that the euro zone is robust or recovering,' said Stephen Pope, managing partner at Spotlight ideas. He further added that bad news from Spain 'traveled to the next in line which from the markets perspective is Italy.'
Unemployment in the Spain rose 0.8% in March to 4.75 million, government figures showed. Separately, Spanish Finance Minister Luis de Guindos told The Wall Street Journal in an interview that there was 'no margin for error' with the government's 2012 budget announced last week. He said Spain's debt-to-gross-domestic-product ratio will likely rise to just over 78% this year from 68.5% in 2011.
Shares of Bankinter SA ES:BKT 'fell 5.9%, Banco Santander SA ES:SAN 'gave up 4%, while BBVA SA ES:BBVA '< span class="quotePeekContainer">BBVA 'shed 4.5%.
Yields were also rising for Italy's 10-year government bonds IT:10YR_ITA ,'adding 10 basis points to 5.14%. Bond prices move inversely to their yields.
In Milan, the FTSE MIB index XX:FTSEMIB 'traded 2% lower at 15,624.23, weighed down by Banca Popolare di Milano SCARL IT:PMI ,'off 6.6%, and Banco Popolare SC IT:BP , down 6.8%.
Click to Play

Gloomy data hit at austerity plans

Dire figures on unemployment and manufacturing activity in the euro-zone's weakest members on Monday highlighted the scale of the currency bloc's economic problems. (Photo: AFP/Getty.)
In the U.S., stocks were mostly lower on Wall Street, pivoting away from gains in the first session of the second quarter. Factory orders for the U.S. rose 1.3% in February, slightly below analysts' estimates, while orders for January were revised down to a 1.1% decline from a prior estimate of a 1.0% drop.
Banks were also lower in France. BNP Paribas SA FR:BNP 'gave up 2.8%, Soci't' G'n'rale SA FR:GLE 'lost 3.7%, while Credit Agricol! e SA FR:ACA 'fell 3.2%. The CAC 40 index FR:PX1 'closed 1.6% lower at 3,406.78.
And in the U.K., shares of Royal Bank of Scotland Group PLC UK:RBS 'RBS 'declined 3.1% and Barclays PLC UK:BARC 'BCS 'lost 2.6%.
The FTSE 100 index UK:UKX 'was 0.6% off at 5,838.34, further pressured by Compass Group PLC UK:CPG , off 1.8%, after Morgan Stanley downgraded the food-service firm to equalweight from overweight. FTSE 100 gives up gains
Bucking the trend, Cairn Energy PLC UK:CNE added 4% outside London's main index. The oil and gas producer bought Agora Oil & Gas, a private Norwegian company, for $450 million in shares and cash.
In Germany, the DAX 30 index DX:DAX gave up 1.1% to 6,982.28, as Commerzbank AG DE:CBK 'shed 3.4% and Deutsche Bank AG DE:DBK ! 'lost 3%.
K+S AG DE:SDF also'weighed on the index, down 1.4% after Nomura Securities downgraded the potash producer to reduce from neutral.
Nomura also downgraded Dutch specialty-chemicals firm Akzo Nobel NV NL:AKZA , down 2.7%, to neutral from buy.
Among notable gainers, Novo Nordisk AS DK:NOVOB , up 2.4%, provided the biggest support in Europe as Bank of America Merrill Lynch added the stock to its Europe 1 list. The Danish firm was also among the biggest gainers on Monday after saying it owns 4.71% of its total share capital, as part of a buyback plan. The Danish OMX Copenhagen 20 index rose 1.3% to 465.15.
Swiss biotech firm Lonza Group AG CH:LONN 'added 1.6%. The company said Richard Ridinger has been appointed as new chief executive effective May 1.
In Brussels, drug maker UCB SA BE:UCB 'added 1.5% after the U.S. Food and Drug Administration approved its Neupro drug for Parkinson's disease treatment.

Best Stocks to buy 2012 Labels